Haemangiopericytoma (HPC) is a rare tumour, characterized by unidentif
iable light microscopic features, Despite first being described over 5
0 years ago, nothing much was known about this tumour until the early
1980s, when ultrastructural studies and tumour markers made it possibl
e to differentiate it from other mesenchymal tumours, Advancements in
radiology and the emergence of MRI technology helped surgeons in bette
r planning, Pre-operative vascular embolization helped to reduce the m
enace of operative haemorrhage, Improvements in localization and deliv
ery of radiotherapy, coupled with early diagnosis, has tremendously im
proved the treatment outcome of haemangiopericytoma.